Best Vitamin D3+K2
in India 2026
4 Indian D3+K2 brands evaluated on IU dose, K2 form (MK-7 vs MK-4), and label transparency. The critical context most Indian brands won't tell you: standard OTC products at 600 IU may not be enough to correct deficiency — and over 70% of urban Indians are deficient. Read the dosing section before buying anything.
Our Best Of hub page previously stated Carbamide Forte D3+K2 contains 5,000 IU D3. This was incorrect. The standard Carbamide Forte D3+K2 MK-7 product (120 tabs, ASIN B097DFLDB8) contains 600 IU D3 + 55mcg MK-7 per tablet. The hub page has been corrected. This category page reflects accurate dosages throughout.
The single most needed supplement in urban India. Over 70% of urban adults are vitamin D insufficient or deficient. The evidence base for D3 supplementation in skeletal health, immune function, and cardiovascular risk is among the strongest of any micronutrient. The D3+K2 combination is mechanistically coherent — K2 directs calcium into bone and away from arterial walls. The category scores 8.6 as an ingredient. Individual Indian products score lower due to dosing limitations.
India's deficiency paradox
Full deep-dive →India receives adequate UVB radiation for D3 synthesis year-round at latitudes below 33°N. Yet a majority of its urban population is vitamin D insufficient. The paradox has a clear explanation: melanin-rich skin requires significantly more UVB exposure to produce equivalent D3 to lighter skin, and urbanisation has dramatically reduced outdoor sun exposure. The combination of high melanin, indoor work, and vegetarian diets (no dietary D3) creates a structural deficiency that sunlight exposure alone cannot readily correct in an urban lifestyle.
Test before you supplement — and know what your number means
A serum 25-OH-D3 test costs ₹400–₹800 at Dr Lal PathLabs, Metropolis, or SRL Diagnostics. Interpreting results: <20 ng/mL = deficient (most Indian urban adults); 20–30 ng/mL = insufficient; 30–50 ng/mL = adequate; 50–80 ng/mL = optimal. If deficient (<20 ng/mL), a 600–2000 IU OTC supplement will take 6–12 months to correct the deficiency. India's clinical standard is the 60,000 IU weekly cholecalciferol sachet (prescription) for 8–12 weeks, followed by 1,000–2,000 IU/day maintenance.
D3 vs D2 · MK-7 vs MK-4
- D3 is 87% more potent at raising 25-OH-D
- D3 has significantly longer tissue half-life
- D3 is the form made in human skin
- D2 is plant-derived, cheaper to synthesise
- Many Indian "Vitamin D" supplements use D2 — check label
- Always choose D3 (cholecalciferol)
- MK-7 half-life: ~72 hours — once-daily dosing works
- MK-4 half-life: 1–2 hours — requires multiple daily doses
- MK-7 at 45–100mcg/day is the studied supplementation dose
- MK-4 trials used pharmacological doses (45mg) impractical for supplements
- MK-4 is common in cheaper gummy formats
- Always choose MK-7 in K2 supplements
The FSSAI dosing context — why most Indian OTC D3 is maintenance-only
FSSAI Schedule II classifies Vitamin D as a health supplement with a recommended daily intake of 600 IU (adults). Products marketed as health supplements typically provide 600–1000 IU to stay within FSSAI guidelines. Higher-dose products (2000–5000 IU) occupy a regulatory grey area — available OTC online but technically beyond the Schedule II health supplement category. For deficiency correction, the Indian clinical standard remains the doctor-prescribed 60,000 IU weekly sachet (available as brands like Calcirol, Cholecalciferol Sachet). OTC 600 IU supplements are appropriate for maintenance in already-replete individuals only.
Brand breakdown
HealthKart HK Vitals D3+K2 is one of the few Indian brands offering a higher D3 dose (reported at approximately 2500 IU per capsule in the current formulation) alongside MK-7 K2 at 55mcg. This dose is the most clinically relevant OTC option — sufficient to maintain adequate 25-OH-D levels (30–50 ng/mL) in most non-severely deficient adults. The MK-7 form is correct.
Verification note: IU content in Indian products can change formulation without prominent labelling updates. Always verify the per-capsule D3 IU on the current label or Amazon product page before purchasing. Our evaluation is based on the formulation available at the time of review (May 2026).
600 IU D3 (cholecalciferol) + 55mcg K2 MK-7 per tablet. 120-tab supply at ₹899 = ₹7.5/day — the best price-per-day for a D3+K2 MK-7 combination in India. The D3 dose (600 IU) is the Indian RDA — appropriate for maintenance in adults who are already at adequate serum D3 levels. It is not sufficient for correcting deficiency efficiently.
Veg-certified, plant-sourced D3 from lichen — the only significant dietary source of D3 for strict vegetarians and vegans. This is a meaningful differentiator for India's vegetarian market. If your 25-OH-D tests adequate (30+ ng/mL) and you want a maintenance supplement, this is the best-value option in India.
600 IU D3 + 55mcg MK-7 per capsule — same formulation as Carbamide Forte at 11% higher cost. The product is FSSAI licensed and uses the correct D3 and MK-7 forms. No substantive differentiation from Carbamide Forte other than capsule vs tablet delivery. At ₹8.32/day vs ₹7.5/day for Carbamide Forte, there is no quality justification for the premium.
Gummy D3+K2 products frequently use MK-4 (synthetic menaquinone-4) rather than MK-7. MK-4 has a 1–2 hour half-life — a once-daily gummy cannot maintain adequate circulating K2 levels. The clinical trials supporting K2 benefits used either MK-7 at 45–100mcg/day (once daily) or MK-4 at 45mg/day (pharmacological doses impractical for supplements). A gummy with 45mcg MK-4 taken once daily is inadequate.
Full comparison — all 4 brands (May 2026 prices)
| Brand | Price | D3 form | D3 IU/cap | K2 form | K2 dose | ₹/day | Score |
|---|---|---|---|---|---|---|---|
H HealthKart HK Vitals D3+K2 60 caps · Best dose | ₹699/60 | D3 ✓ | ~2500 IU* | MK-7 ✓ | 55mcg | ₹11.65 | 8.3 |
C Carbamide Forte D3+K2 MK-7 120 tabs · Best value maintenance | ₹899/120 | D3 (lichen) ✓ | 600 IU | MK-7 ✓ | 55mcg | ₹7.5 | 7.8 |
H Himalayan Organics D3+K2 120 caps | ₹999/120 | D3 ✓ | 600 IU | MK-7 ✓ | 55mcg | ₹8.32 | 7.6 |
G MK-4 Gummies (various brands) 30–60 units | ₹400–700 | D3 ✓ | 500–1000 IU | MK-4 ✗ | 45–100mcg | ₹13–23 | 6.2 |
* HealthKart IU noted as approximate — verify current label before purchase. Formulations can change without prominent notice.
Scoring rubric
How we score →1. Evidence quality
Martineau et al. (2017) meta-analysis of 25 RCTs confirms D3 reduces respiratory infection incidence. Bischoff-Ferrari et al. (2009) confirms fracture risk reduction. VDR signalling is mechanistically established in immune, bone, and cardiovascular pathways. The D3+K2 combination evidence (Knapen et al. 2015 — vascular calcification) is promising but smaller. K2 MK-7 evidence alone is good for bone and emerging for cardiovascular. Minor deduction for heterogeneity across D3 trials and ongoing debate about optimal serum target (30 vs 40 vs 50 ng/mL).
2. Dosage confidence
Maintenance at 1,000–2,000 IU D3/day is well-supported for sustaining adequate serum levels. For deficiency correction: 4,000–6,000 IU/day or the Indian standard of 60,000 IU weekly. K2 MK-7 at 45–100mcg/day is the studied range. The dosage range is well-defined, but the appropriate dose depends on baseline serum levels — hence the recommendation to test first. Without testing, dosing is imprecise.
3. India market fit
The highest India-fit score in this guide. The need is structural, documented, and widespread — not speculative. The combination of high melanin, indoor urban lifestyle, and vegetarian diets creates a uniquely severe deficiency situation. FSSAI Schedule II compliant. Plant-based D3 (lichen-sourced) is available for vegetarian/vegan buyers. Products are widely available at ₹7.5–₹11.65/day. The only meaningful gap: most OTC products provide maintenance-level doses, not deficiency-correction doses.
4. Safety profile
D3 at 1,000–4,000 IU/day is safe in adults with normal kidney function. Toxicity (hypercalcaemia) occurs above 10,000 IU/day sustained over months — not a concern with OTC Indian supplements at 600–2500 IU. K2 MK-7 has an excellent safety profile with no known toxicity. Minor deduction for the rare interaction between high-dose K2 and warfarin (K2 can reduce warfarin efficacy — avoid combination without haematologist oversight).
5. Label accuracy
Multiple label accuracy issues: (1) D3 vs D2 not always clearly identified — look for "cholecalciferol" specifically. (2) MK-4 vs MK-7 not prominently distinguished — gummy products commonly use MK-4 without prominently communicating the limitation. (3) IU content can change formulation without prominent notice. The category loses marks because even well-intentioned products require careful label reading to confirm the decision criteria that matter most (form and dose).
How to use it
Frequently asked
Why is India so vitamin D deficient despite abundant sunlight?
MK-7 vs MK-4 — what's the practical difference?
Do I need to test my vitamin D level before supplementing?
Why is there a D3+K2 combination — what does K2 add?
Related content
Vitamin D3 — Full Evidence Review
VDR mechanism, India deficiency data, D3 vs D2, serum target controversy, and reference list.
Vitamin K2 MK-7 — Evidence Review
MGP/osteocalcin mechanism, MK-7 vs MK-4 pharmacokinetics, bone and vascular evidence.
Best Of — All 6 Categories
Creatine, omega-3, whey, ashwagandha, magnesium. All brands on the same 5-dimension rubric.
Affiliate disclosure. Naked Compound participates in the Amazon Associates India programme. Commission does not influence scores or rankings. conflicts-policy